Literature DB >> 11278370

Vanadate facilitates interferon alpha-mediated apoptosis that is dependent on the Jak/Stat pathway.

A M Gamero1, A C Larner.   

Abstract

Type I interferon (IFN)-dependent inhibition of cell growth can occur either in the absence or presence of apoptosis. The mechanisms that determine whether or not cells undergo apoptosis after exposure to IFN-alpha are not clear. This study shows that a variety of cell lines that display growth inhibition but not apoptosis in response to IFN-alpha will undergo programmed cell death when low concentrations of the protein-tyrosine phosphatase inhibitor vanadate are added with IFN-alpha. In contrast, the combination of tumor necrosis factor-alpha with vanadate did not trigger apoptosis in these cells. Caspase-3 activity was detected only in cells exposed to IFN-alpha and vanadate but not to IFN-alpha or vanadate alone. The ability of IFN-alpha and vanadate to induce apoptosis did not require expression of p53 and was blocked by N-acetyl-l-cysteine. Activation of the Jak/Stat pathway and expression of IFN-inducible genes was not altered by incubation of cells with IFN-alpha and vanadate compared with IFN-alpha alone. However, mutant cells lacking Stat1, Stat2, Jak1, or Tyk2, or cells expressing kinase inactive Jak1 or Tyk2 did not undergo apoptosis in the presence of IFN-alpha and vanadate. These results suggest that IFN-alpha stimulation of Stat-dependent genes is necessary, but not sufficient, for this cytokine to induce apoptosis. Another signaling cascade that involves the activity of a protein-tyrosine phosphatase and/or the generation of reactive oxygen species may play an important role in promoting IFN-alpha-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278370     DOI: 10.1074/jbc.M007948200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  STAT2 contributes to promotion of colorectal and skin carcinogenesis.

Authors:  Ana M Gamero; Matthew R Young; Roycelynn Mentor-Marcel; Gerd Bobe; Anthony J Scarzello; Jennifer Wise; Nancy H Colburn
Journal:  Cancer Prev Res (Phila)       Date:  2010-03-16

2.  In situ expression of 15 kDa interferon alpha responsive gene in the developing tooth germ of the mouse lower first molar.

Authors:  Merina Akhter; Ieyoshi Kobayashi; Tamotsu Kiyoshima; Kengo Nagata; Hiroko Wada; Yukiko Ookuma; Hiroaki Fujiwara; Jyun-Ya Honda; Hidetaka Sakai
Journal:  J Mol Histol       Date:  2010-07-11       Impact factor: 2.611

Review 3.  Interferons as inducers of apoptosis in malignant cells.

Authors:  Kevin P Kotredes; Ana M Gamero
Journal:  J Interferon Cytokine Res       Date:  2013-04       Impact factor: 2.607

4.  Vanadium compounds discriminate hepatoma and normal hepatic cells by differential regulation of reactive oxygen species.

Authors:  Qin Wang; Tong-Tong Liu; Ying Fu; Kui Wang; Xiao-Gai Yang
Journal:  J Biol Inorg Chem       Date:  2010-05-05       Impact factor: 3.358

5.  Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds.

Authors:  Mohammed Selman; Christopher Rousso; Anabel Bergeron; Hwan Hee Son; Ramya Krishnan; Nader A El-Sayes; Oliver Varette; Andrew Chen; Fabrice Le Boeuf; Fanny Tzelepis; John C Bell; Debbie C Crans; Jean-Simon Diallo
Journal:  Mol Ther       Date:  2017-10-24       Impact factor: 11.454

6.  Down-regulation of JAK1 by RNA interference inhibits growth of the lung cancer cell line A549 and interferes with the PI3K/mTOR pathway.

Authors:  Dan Liu; Yi Huang; Jing Zeng; Bojiang Chen; Na Huang; Na Guo; Lunxu Liu; Hong Xu; Xianming Mo; Weimin Li
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-23       Impact factor: 4.553

7.  Tyk2 tyrosine kinase expression is required for the maintenance of mitochondrial respiration in primary pro-B lymphocytes.

Authors:  Ramesh Potla; Thomas Koeck; Joanna Wegrzyn; Srujana Cherukuri; Kazuya Shimoda; Darren P Baker; Janice Wolfman; Sarah M Planchon; Christine Esposito; Brian Hoit; Jozef Dulak; Alan Wolfman; Dennis Stuehr; Andrew C Larner
Journal:  Mol Cell Biol       Date:  2006-09-18       Impact factor: 4.272

Review 8.  The past, present and future of immunotherapy against tumor.

Authors:  Tao Jiang; Caicun Zhou
Journal:  Transl Lung Cancer Res       Date:  2015-06

9.  Resistance to IFN-alpha-induced apoptosis is linked to a loss of STAT2.

Authors:  Ana L Romero-Weaver; Hsiang-Wen Wang; Håkan C Steen; Anthony J Scarzello; Veronica L Hall; Faruk Sheikh; Raymond P Donnelly; Ana M Gamero
Journal:  Mol Cancer Res       Date:  2010-01-12       Impact factor: 5.852

10.  Host STAT2/type I interferon axis controls tumor growth.

Authors:  Chanyu Yue; Jun Xu; Marc Daryl Tan Estioko; Kevin P Kotredes; Yolanda Lopez-Otalora; Brendan A Hilliard; Darren P Baker; Stefania Gallucci; Ana M Gamero
Journal:  Int J Cancer       Date:  2014-06-17       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.